Quarterly report pursuant to Section 13 or 15(d)

Significant Accounting Policies (Narrative) (Details)

v3.5.0.2
Significant Accounting Policies (Narrative) (Details)
shares in Millions
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 08, 2016
USD ($)
Jan. 31, 2010
right
Jun. 30, 2016
USD ($)
Jun. 30, 2015
USD ($)
Jun. 30, 2016
USD ($)
segment
Jun. 30, 2015
USD ($)
shares
Dec. 31, 2015
USD ($)
Aug. 31, 2014
USD ($)
Property, Plant and Equipment [Line Items]                
Number of operating segments | segment         1      
Earnings (Loss) Per Share                
Common shares excluded from computation | shares           5.3    
Cash, Cash Equivalents and Short-term Investments                
Maturity period of cash and cash equivalents, maximum         3 months      
Maturity period of short term investments, minimum         3 months      
Inventory, Net [Abstract]                
Inventory write downs     $ 0 $ 0 $ 0 $ 0    
Goodwill and Other Identifiable Intangible Assets                
Finite-lived intangible asset, useful life         20 years      
Amortization expense     2,700,000 600,000 $ 5,200,000 1,200,000    
Impairment of goodwill             $ 0  
Property and Equipment                
Depreciation     100,000     100,000    
Contingent Liabilities                
Purchase of commercial license rights         $ 92,504,000 0    
Revenue Recognition                
Restocking fee (percent)         20.00%      
Minimum                
Revenue Recognition                
Period when partner sales reports are received after end of quarter         30 days      
Maximum                
Revenue Recognition                
Period when partner sales reports are received after end of quarter         60 days      
Equipment | Minimum                
Property and Equipment                
Estimated useful life of assets         3 years      
Equipment | Maximum                
Property and Equipment                
Estimated useful life of assets         10 years      
OMT, Inc.                
Property, Plant and Equipment [Line Items]                
Goodwill acquired $ 60,100,000              
Finite-lived intangible assets $ 167,000,000              
Cydex Pharmaceuticals, Inc                
Contingent Liabilities                
Fair value of liability     7,000,000   $ 7,000,000   9,500,000  
Contingent liability change in amount     (200,000) (1,000,000) (500,000) (2,200,000)    
Cydex Pharmaceuticals, Inc | Revenue Sharing                
Contingent Liabilities                
Purchase of commercial license rights     3,000,000     3,200,000    
Metabasis Therapeutics                
Contingent Liabilities                
Fair value of liability     2,500,000   2,500,000   4,000,000  
Contingent liability change in amount     100,000 $ 6,400,000 1,200,000 5,300,000    
Number of contingent value rights | right   4            
Number of contingent value rights per series of contingent value rights | right   1            
Number of contingent value rights issued for each share | right   4            
Contingent value rights, frequency of cash payment   6 months            
Contingent liability, cash payment         2,600,000 $ 0    
2019 convertible senior notes                
Convertible Debt                
Principal amount outstanding     $ 245,000,000   $ 245,000,000   $ 245,000,000  
2019 convertible senior notes | Senior Notes                
Convertible Debt                
Principal amount outstanding               $ 245,000,000.0
Interest rate               0.75%
Director [Member]                
Relationships between the CorMatrix Parties                
Mr. Aryeh's owenership percentage in CorMatrix (percent)     0.56%   0.56%